New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange (Q46453010)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2005

edit

Language	Label	Description	Also known as
English	New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange	scientific article published in March 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

title

New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

main subject

liver transplantation

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

author name string

Kawagishi N

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Satoh K

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Enomoto Y

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Akamatsu Y

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Sekiguchi S

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Fukumori T

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Fujimori K

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

Satomi S

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

language of work or name

English

0 references

publication date

1 March 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

published in

Transplantation Proceedings

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

volume

37

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

page(s)

1205-1206

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

cites work

Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.114

retrieved

7 January 2021

Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.114

retrieved

7 January 2021

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.114

retrieved

7 January 2021

Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.114

retrieved

7 January 2021

Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.114

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.TRANSPROCEED.2004.12.114

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

PubMed publication ID

15848670

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15848670

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15848670

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46453010&oldid=2112418909"